New hope for rare sarcoma? drug combo tested in 44 patients

This study tested whether adding the immunotherapy drug durvalumab to standard chemotherapy (doxorubicin) could help people with advanced soft tissue sarcoma that has spread or come back. The trial included 44 adults whose cancer could be measured and who were healthy enough for treatment. The main goal was to check safety and see if the combination works better than chemo alone.